- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04497844
Une étude sur le niraparib en association avec l'acétate d'abiratérone et la prednisone par rapport à l'acétate d'abiratérone et à la prednisone pour le traitement des participants atteints d'un cancer de la prostate délétère de la lignée germinale ou de la réparation somatique par recombinaison homologue (HRR) métastatique métastatique sensible à la castration (mCSPC) (AMPLITUDE)
Une étude de phase 3 randomisée, contrôlée par placebo et en double aveugle sur le niraparib en association avec l'acétate d'abiratérone et la prednisone par rapport à l'acétate d'abiratérone et à la prednisone pour le traitement des participants atteints d'une lignée germinale délétère ou d'une réparation par recombinaison homologue somatique (HRR) mutée par un gène métastatique sensible à la castration Cancer de la prostate (mCSPC)
The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS).
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Réel)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
-
Cape Town, Afrique du Sud, 7700
- CancerCare Rondebosch
-
Pretoria, Afrique du Sud, 0001
- Steve Biko Academic Hospital
-
Vosloorus, Afrique du Sud, 1475
- East Rand Urology Research Unit
-
-
-
-
-
Braunschweig, Allemagne, 38126
- Städtisches Klinikum Braunschweig gGmbH - Standort Salzdahlumer
-
Cologne, Allemagne, 50937
- Universitaetsklinikum Koelnt
-
Dresden, Allemagne, 01307
- Universitätsklinik Carl Gustav Carus, Med. Klinik u. Poliklinik I
-
Duisburg, Allemagne, 47169
- Urologicum Duisburg
-
Hanover, Allemagne, 30625
- Medizinische Hochschule Hannover
-
München, Allemagne, 81675
- Klinikum rechts der Isar - III. Med. Klinik und Poliklinik
-
Münster, Allemagne, 48149
- Universitaetsklinikum Muenster
-
Nürtingen, Allemagne, 72622
- Studienpraxis Urologie Drs. Feyerabend
-
-
-
-
-
Buenos Aires, Argentine, C1419AHN
- Asociacion de Beneficencia Hospital Sirio Libanes
-
Buenos Aires, Argentine, C1426AGE
- Centro Oncológico Korben
-
Buenos Aires, Argentine, C1061AAS
- CIPREC
-
C.a.b.a., Argentine, C1426BOR
- Hospital Militar Cosme Argerich
-
Caba, Argentine, C1056ABI
- CINME Centro de Investigaciones Metabolicas
-
Ciudad Automoma Buenos Aires, Argentine, C1120AAT
- Centro de Urologia (CDU)
-
Ciudad Autonoma de, Argentine, C1199ABB
- Hospital Italiano de Buenos Aires
-
Ciudad de Buenos Aires, Argentine, C1430EGF
- Clinica Adventista Belgrano
-
Córdoba, Argentine, 5000
- Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
-
Córdoba, Argentine, X5000KPH
- Centro Urologico Profesor Bengio
-
Córdoba, Argentine, X5800
- Instituto Médico de Río Cuarto
-
Córdoba, Argentine, XX5016KEH
- Hospital Privado de Cordoba
-
Mar del Plata, Argentine, B7602CBM
- Hospital Privado de Comunidad
-
Pergamino, Argentine, B2700CPM
- Centro de Investigacion Pergamino SA
-
San Salvador de Jujuy, Argentine, Y4600AFW
- ARS Médica
-
-
-
-
-
Birtinya, Australie, 4575
- Sunshine Coast University Hospital
-
Darlinghurst, Australie, 2010
- St Vincent s Hospital Sydney
-
Herston, Australie, 4029
- Cancer Care Services Clinical Research Unit
-
Hobart, Australie, 7000
- Royal Hobart Hospital
-
Kurralta Park, Australie, 5037
- Icon Cancer Centre Kurralta Park
-
Liverpool, Australie, 2170
- Liverpool Hospital
-
Melbourne, Australie, 3000
- Peter MacCallum Cancer Centre
-
Murdoch, Australie, 6150
- Fiona Stanley Hospital
-
North Ryde, Australie, 2109
- Macquarie University Hospital
-
South Brisbane, Australie, 4101
- ICON Cancer Care
-
Subiaco, Australie, 6008
- St John of God Subiaco Hospital
-
-
-
-
-
Antwerp, Belgique, 2020
- ZNA Middelheim
-
Antwerp, Belgique, 2610
- ZAS Augustinus
-
Charleroi, Belgique, 6060
- Grand Hopital De Charleroi Site Les Viviers
-
Haine-St-Paul, Belgique, 7100
- Jolimont
-
Liège, Belgique, 4000
- CHC MontLegia
-
Namur, Belgique, 5000
- CHU UCL Namur - Site Sainte Elisabeth
-
Ottignies, Belgique, 1340
- Clinique St Pierre
-
Roeselare, Belgique, 8800
- Algemeen Ziekenhuis Delta
-
-
-
-
-
Babruysk, Biélorussie, 213825
- Bobruisk Interregional Oncology Dispensary
-
Brest, Biélorussie, 224027
- Brest Regional Oncology Dispensary
-
Grodno, Biélorussie, 230017
- Grodno University Hospital
-
Homyel, Biélorussie, 246012
- Gomel Regional Clinical Oncology Dispensary
-
Lesnoy, Biélorussie, 223040
- N N Alexandrov National Cancer Centre of Belarus
-
Minsk, Biélorussie, 220013
- Minsk city Clinical Oncological Dispensary
-
Mogilev, Biélorussie, 212018
- Mogilev Regional Oncology Dispensary
-
Vitebsk, Biélorussie, 210603
- Vitebsk Regional Clinical Oncology Dispensary
-
-
-
-
-
Barretos, Brésil, 14784-400
- Fundacao Pio XII
-
Belo Horizonte, Brésil, 30110-022
- Cetus Oncologia
-
Belo Horizonte, Brésil, 30130-090
- PERSONAL Oncologia de Precisao e Personalizada
-
Curitiba, Brésil, 80810 050
- CIONC Centro Integrado de Oncologia de Curitiba
-
Florianópolis, Brésil, 88020 210
- Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina
-
Fortaleza, Brésil, 60 810180
- Pronutrir
-
Goiânia, Brésil, 74605-070
- Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
-
Ipatinga, Brésil, 35162 189
- Fundacao Sao Francisco Xavier
-
Joinville, Brésil, 89201-260
- Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia
-
Natal, Brésil, 59075-740
- Liga Norte Riograndense Contra O Cancer
-
Pelotas, Brésil, 96020 080
- UPCO Unidade de Pesquisa Clinica em Oncologia
-
Porto Alegre, Brésil, 90020-090
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Porto Alegre, Brésil, 90160-093
- Hospital Ernesto Dornelles
-
Recife, Brésil, CEP: 50070
- MultiHemo Servicos Medicos S.A
-
Rio de Janeiro, Brésil, 20551-030
- Universidade do Estado do Rio de Janeiro - UERJ
-
Rio de Janeiro, Brésil, 22250 905
- Oncoclinicas Rio de Janeiro S A
-
Rio de Janeiro, Brésil, 20230-130
- Ministerio da Saude Instituto Nacional do Cancer
-
Rio de Janeiro, Brésil, 22775 001
- Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
-
Salvador, Brésil, 40170 110
- Nucleo de Oncologia da Bahia
-
Salvador, Brésil, 41253 190
- Hospital Sao Rafael
-
Santo André, Brésil, 09060 870
- Fundacao do ABC Centro Universitario FMABC
-
Sorocaba, Brésil, 18030-005
- IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
-
São Paulo, Brésil, 04014-002
- Núcleo de Pesquisa São Camilo
-
São Paulo, Brésil, 01236-030
- Instituto de Ensino e Pesquisa São Lucas
-
São Paulo, Brésil, 01221 020
- Instituto do Cancer Arnaldo Vieira de Carvalho
-
São Paulo, Brésil, 04039-004
- Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE
-
São Paulo, Brésil, 01246 000
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, Brésil, 01221-020
- Irmandade Santa Casa de Misericordia de Sao Paulo
-
São Paulo, Brésil, 01421-000
- Hospital Alemao Oswaldo Cruz
-
São Paulo, Brésil, 01323 900
- Real e Benemerita Associacao Portuguesa de Beneficencia
-
Uberlândia, Brésil, 38408-150
- Centro Oncológico do Triângulo
-
-
-
-
-
Burgas, Bulgarie, 8001
- MHAT Deva Maria
-
Pleven, Bulgarie, 5800
- UMHAT Dr Georgi Stranski EAD 1
-
Plovdiv, Bulgarie, 4004
- Complex Oncology Center - Plovdiv EOOD
-
Sofia, Bulgarie, 1756
- Specialized Hospital for Active Treatment in Oncology
-
Sofia, Bulgarie, 1797
- UMHAT Sofia Med
-
Sofia, Bulgarie, 1330
- Multifunctional Hospital for Active Treatment for Women Health Nadezhda
-
Vratsa, Bulgarie, 3001
- Comprehensive Cancer Center
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2V 1P9
- Prostate Cancer Centre
-
Edmonton, Alberta, Canada, T6G 1Z2
- Cross Cancer Institute
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 5L3
- British Columbia Cancer Agency(BCCA)-Sindi Ahluwalia Hawkins Centre for the Southern Interior(CSI)
-
Vancouver, British Columbia, Canada, V5Z 4E6
- British Columbia Cancer Agency BCCA Vancouver Centre
-
Victoria, British Columbia, Canada, V8R 6V5
- British Columbia Cancer Agency Vancouver Island Centre
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 4A6
- McMaster Institute of Urology
-
Kingston, Ontario, Canada, K7L2V7
- Kingston Health Sciences Centre, Kingston General Health Research Institute
-
Toronto, Ontario, Canada, M5G2M9
- Princess Margaret Cancer Centre University Health Network
-
Toronto, Ontario, Canada, M4N 3M5
- Sunnybrook Health Sciences Center
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E2
- McGill University - Jewish General Hospital
-
Montreal, Quebec, Canada, H2X 0A9
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Beijing, Chine, 100142
- Beijing Cancer Hospital
-
Beijing, Chine, 100730
- Beijing Hospital
-
Beijing, Chine, 100034
- Peking University First Hospital
-
Beijing, Chine, 100021
- Cancer Hospital Chinese Academy of Medical Sciences
-
Beijing, Chine, 100191
- Beijing University Third Hospital
-
Beijing, Chine, 100050
- Beijing Friendship Hospital Capital Medical University
-
Chengdu, Chine, 610041
- West China Hospital of Sichuan University
-
Chengdu, Chine, 610083
- Western Theater General Hospital of the Chinese People's Liberation Army
-
Chengdu, Chine, 610072
- Sichuan Provincial Peoples Hospital
-
Chongqing, Chine, 400030
- Chongqing University Cancer Hospital
-
Chongqing, Chine, 400038
- Southwest Hospital, The Third Military Medical University
-
Guangzhou, Chine, 510180
- Guangzhou First Municipal People's Hospital
-
Guangzhou, Chine, 510289
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
-
Guangzhou, Chine, 430030
- Sun Yat Sen University Cancer Center
-
Hangzhou, Chine, 310014
- Zhejiang Provincial People's Hospital
-
Nanchang, Chine, 330006
- The First Affiliated Hospital of NanChang University
-
Nanjing, Chine, 210008
- Nanjing Drum Tower Hospital
-
Nanjing, Chine, 210000
- Jiangsu Province Cancer Hospital
-
Ningbo, Chine, 315010
- The First Affiliated Hospital of Ningbo University
-
Shanghai, Chine, 200032
- Fudan University Shanghai Cancer Center
-
Shanghai, Chine, 200040
- Huashan Hospital Fudan University
-
Shanghai, Chine, 200240
- The Fifth People's Hospital of Shanghai, Fudan University
-
Shanghai, Chine, 200127
- Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University
-
Shanghai, Chine, 200400
- Huadong Hospital Affiliated to Fudan University
-
Shenyang, Chine, 110004
- Shengjing Hospital Of China Medical University
-
Suzhou, Chine, 215006
- The First Affliated Hospital of Soochow University
-
Suzhou, Chine, 200233
- Second Affiliated Hospital of Soochow University
-
Wenzhou, Chine, 325000
- The First Affiliated Hospital of Wenzhou Medical University
-
Wuhan, Chine, 430030
- TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology
-
Xi'an, Chine, 710061
- The First Affiliated Hospital of Xian Jiaotong University
-
-
-
-
-
Busan, Corée du Sud, 49241
- Pusan National University Hospital
-
Daegu, Corée du Sud, 41404
- Kyungpook National University Chilgok Hospital
-
Daegu, Corée du Sud, 42601
- Keimyung University Dongsan Hospital
-
Daejeon, Corée du Sud, 35015
- Chungnam National University Hospital
-
Gwangju, Corée du Sud, 61469
- Chonnam National University Hospital
-
Gyeonggi-do, Corée du Sud, 10408
- National Cancer Center
-
Seongnam-si, Corée du Sud, 13620
- Seoul National University Bundang Hospital
-
Seoul, Corée du Sud, 03080
- Seoul National University Hospital
-
Seoul, Corée du Sud, 05505
- Asan Medical Center
-
Seoul, Corée du Sud, 03722
- Severance Hospital Yonsei University Health System
-
Seoul, Corée du Sud, 06351
- Samsung Medical Center
-
Seoul, Corée du Sud, 06591
- The Catholic University of Korea Seoul St Mary s Hospital
-
Seoul, Corée du Sud, 06273
- Gangnam Severance Hospital, Yonsei University Health System
-
Suwon, Corée du Sud, 16499
- Ajou University Hospital
-
-
-
-
-
Aalborg, Danemark, 9000
- Aalborg University Hospital
-
Copenhagen, Danemark, 2100
- Copenhagen University Hospital
-
Herlev, Danemark, DK-2730
- Herlev Hospital
-
Næstved, Danemark, 4700
- Næstved Hospital
-
Odense, Danemark, DK-5000
- Odense Universitetshospital
-
Vejle, Danemark, DK-7100
- Vejle Hospital
-
-
-
-
-
A Coruña, Espagne, 15006
- Hosp Univ A Coruna
-
Barcelona, Espagne, 08025
- Hosp. de La Santa Creu I Sant Pau
-
Barcelona, Espagne, 08036
- Hosp Clinic de Barcelona
-
Castellon, Espagne, 12004
- Hosp. Gral. Univ. de Castellon
-
Girona, Espagne, 17007
- Institut Català D'Oncologia Girona
-
Jerez de la Frontera, Espagne, 11407
- Hosp. de Jerez de La Frontera
-
Madrid, Espagne, 28041
- Hosp. Univ. 12 de Octubre
-
Madrid, Espagne, 28034
- Hosp. Univ. Ramon Y Cajal
-
Madrid, Espagne, 28046
- Hosp. Univ. La Paz
-
Madrid, Espagne, 28006
- Hosp. Univ. de La Princesa
-
Madrid, Espagne, 28660
- Hosp. Univ. Hm Monteprincipe
-
Málaga, Espagne, 29010
- Hosp Virgen de La Victoria
-
Sabadell, Espagne, 08208
- Corporacio Sanitari Parc Tauli
-
Santander, Espagne, 39008
- Hosp. Univ. Marques de Valdecilla
-
Seville, Espagne, 41013
- Hosp. Virgen Del Rocio
-
Valencia, Espagne, 46010
- Hosp. Clinico Univ. de Valencia
-
-
-
-
-
Angers, France, 49933
- Institut de Cancerologie de l Ouest ICO
-
Avignon, France, 84918
- Institut Sainte Catherine
-
Besançon, France, 25030
- CHRU De Besancon
-
Bordeaux, France, 33000
- Institut Bergonie
-
Clermont-Ferrand, France, 63011
- Centre Jean Perrin
-
Dijon, France, 21000
- Centre Georges Francois Leclerc
-
Lille, France, 59000
- Centre Oscar Lambret
-
Lyon, France, 69008
- Hopital Prive Jean Mermoz
-
Lyon, France, 69008
- Centre Leon Berard
-
Montpellier, France, 34298
- Institut Regional du Cancer de Montpellier Val d'Aurelle
-
Nancy, France, 54100
- Polyclinique de Gentilly
-
Poitiers, France, 86021
- CHU De Poitiers
-
Quimper, France, 29000
- Centre Hopitalier Inter-Communal De Cornouaille
-
Saint-Mandé, France, 94163
- HIA Begin
-
Saint-Priest-en-Jarez, France, 42271
- Institut de Cancérologie de Loire
-
Strasbourg, France, 67000
- Clinique Sainte Anne
-
Suresnes, France, 32151
- Hopital Foch
-
Tours, France, 37044
- CHRU de Tours
-
-
-
-
-
Budapest, Hongrie, 1204
- Jahn Ferenc Del-pesti Korhaz es Rendelointezet
-
Debrecen, Hongrie, 4032
- Debreceni Egyetem
-
Gyula, Hongrie, 5700
- Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
-
Győr, Hongrie, 9024
- Petz Aladar Megyei Oktato Korhaz
-
Miskolc, Hongrie, 3526
- Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz
-
Szeged, Hongrie, 6720
- Szegedi Tudomanyegyetem
-
Tatabánya, Hongrie, 2800
- Szent Borbala Hospital Tatabanya
-
-
-
-
-
Afula, Israël, 1834111
- Haemek Medical Center - Afula
-
Beersheba, Israël, 85101
- Soroka Hospital
-
Haifa, Israël, 31096
- Rambam Medical Center
-
Jerusalem, Israël, 91200
- Hadassah Hospital
-
Petach Tikvah, Israël, 49100
- Rabin Medical Center, Beilinson Hospital
-
Ramat Gan, Israël, 52621
- Sheba Medical Center Tel Hashomer
-
Tel Aviv, Israël, 64239
- Tel Aviv Sourasky Medical Center
-
-
-
-
-
Arezzo, Italie, 52100
- Ospedale S. Donato - Asl 8 Arezzo
-
Candiolo, Italie, 10060
- Divisione di Oncologia - Istituto per la ricerca e cura del cancro
-
Cremona, Italie, 26100
- Istituti Ospitalieri di Cremona, AO di Cremona
-
Lecce, Italie, 73100
- Azienda Ospedaliera ''Vito Fazzi''
-
Meldola, Italie, 47014
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
-
Milan, Italie, 20132
- Ospedale San Raffaele
-
Milan, Italie, 20133
- Fondazione IRCCS Istituto Nazionale dei Tumori
-
Milan, Italie, 20141
- European Institute of Oncology
-
Naples, Italie, 80138
- Fondazione G Pascale Istituto Nazionale Tumori IRCCS
-
Orbassano, Italie, 10043
- Aou San Luigi Gonzaga
-
Padova, Italie, 35128
- Istituto Oncologico Veneto Iov Irccs Padova
-
Pisa, Italie, 56126
- Azienda Ospedaliero Universitaria Pisana
-
Pozzuoli, Italie, 80078
- ASL Napoli 2 Nord-SM delle Grazie Hospital
-
San Giovanni Rotondo, Italie, 71013
- Casa Sollievo Della Sofferenza IRCCS
-
Trento, Italie
- Ospedale S. Chiara
-
Vicenza, Italie, 36100
- Ospedale San Bortolo
-
-
-
-
-
Almada, Le Portugal, 2805-607
- Uls Almada Seixal - Hosp. Garcia de Orta
-
Coimbra, Le Portugal, 3000075
- Instituto Português de Oncologia Francisco Gentil - Centro Regional de Oncologia de Coimbra, S.A.
-
Lisbon, Le Portugal, 1400-038
- Fund. Champalimaud
-
Lisbon, Le Portugal, 1649 035
- Uls Santa Maria - Hosp. Santa Maria
-
-
-
-
-
George Town, Malaisie, 10990
- Hospital Pulau Pinang
-
Johor Bahru, Malaisie, 81100
- Hospital Sultan Ismail
-
Kuala Lumpur, Malaisie, 50586
- Hospital Kuala Lumpur
-
Kuala Lumpur, Malaisie, 59100
- University Malaya Medical Centre
-
Kuching, Malaisie, 93586
- Sarawak General Hospital
-
Putrajaya, Malaisie, 62250
- Institut Kanser Negara Clinical Research Center
-
-
-
-
-
Durango, Mexique, 34000
- Consultorio de Especialidad en Urologia Privado
-
León, Mexique, 37000
- Consultorio Privado
-
Mexico City, Mexique, 3720
- Centro de Investigacion Clínica Gramel S.C.1
-
Monterrey, Mexique, 64710
- i Can Oncology Center
-
Monterrey, Mexique, 64710
- Avix Investigacion Clinica S C
-
Naucalpan, Mexique, 53100
- Oncologia Integral Satelite
-
Oaxaca City, Mexique, 68020
- Centro de Investigacion Clinica de Oaxaca
-
Zapopan, Mexique, 45040
- Consultorio Privado 1
-
-
-
-
-
Auckland, Nouvelle-Zélande, 1023
- Auckland City Hospital
-
Christchurch, Nouvelle-Zélande, 8013
- Canterbury Urology Research Trust
-
Dunedin Central, Nouvelle-Zélande, 9016
- Dunedin Hospital
-
Tauranga, Nouvelle-Zélande, 3112
- Tauranga Hospital
-
-
-
-
-
Delft, Pays-Bas, 2625 AD
- Reinier de Graaf Gasthuis
-
Hilversum, Pays-Bas, 1213XZ
- Tergooiziekenhuizen
-
Nijmegen, Pays-Bas, 6532 SZ
- Canisius-Wilhelminaziekenhuis
-
Tilburg, Pays-Bas, 5022 GC
- Elisabeth-TweeSteden Ziekenhuis
-
-
-
-
-
Bydgoszcz, Pologne, 85 048
- IN VIVO Sp. z o.o
-
Bydgoszcz, Pologne, 85 094
- Szpital Uniwersytecki NR 1 IM Dr Antoniego Jurasza
-
Bydgoszcz, Pologne, 85 796
- Centrum Onkologii im Prof F Lukaszczyka
-
Gdynia, Pologne, 81 519
- Szpitale Pomorskie Sp z o o
-
Konin, Pologne, 62-500
- Przychodnia Lekarska KOMED Roman Karaszewski
-
Krakow, Pologne, 30 539
- Klinika MedTrials
-
Lodz, Pologne, 93-509
- Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
-
Lublin, Pologne, 20-223
- Medisport
-
Siedlce, Pologne, 08-110
- Urologica Praktyka Lekarska Adam Marcheluk
-
Warsaw, Pologne, 04 073
- Szpital Grochowski Im Dr Med Rafala Masztaka Sp Z O O
-
Wroclaw, Pologne, 53-329
- Specjalistyczna przychodnia lekarska POLIMED
-
-
-
-
-
Hato Rey, Porto Rico, 00917
- Puerto Rico Medical Research Center
-
-
-
-
-
Bangor, Royaume-Uni, LL57 2PW
- Ysbyty Gwynedd
-
Belfast, Royaume-Uni, BT9 7AB
- Belfast City Hospital
-
Brighton, Royaume-Uni, BN2 5BE
- Brighton and Sussex University Hospitals NHS Trust
-
Bristol, Royaume-Uni, BS2 8ED
- Bristol Haematology and Oncology Centre
-
Great Maze Pond, Royaume-Uni, SE1 9RT
- Guy's Hospital
-
Grimsby, Royaume-Uni, DN33 2BA
- Prince Of Wales Hospital
-
Hillingdon, Royaume-Uni, HA6 2RN
- Marie Curie Research Wing - Mount Vernon Hospital
-
Inverness, Royaume-Uni, IV2 3UJ
- Raigmore Hospital
-
London, Royaume-Uni, NW1 2PG
- University College London Hospitals NHSFT
-
Oxford, Royaume-Uni, OX3 7LE
- Churchill Hospital
-
Preston, Royaume-Uni, PR2 9HT
- Royal Preston Hospital
-
Sutton, Royaume-Uni, SM2 5PT
- Royal Marsden Hospital
-
Truro, Royaume-Uni, TR1 3LJ
- Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
-
-
-
-
-
Barnaul, Russie, 656045
- Altai Regional Oncology Dispensary
-
Chelyabinsk, Russie, 454087
- Chelyabinsk Regional Clinical Center Of Oncology And Nuclear Medicine
-
Ivanovo, Russie, 153040
- Ivanovo Regional Oncology Dispensary
-
Moscow, Russie, 125130
- Moscow City Clinical Hospital # 62
-
Moscow, Russie, 125284
- Hertzen Oncology Research Institute
-
Nizhny Novgorod, Russie, 603001
- Privolzhsky District Medical Centre
-
Omsk, Russie, 644013
- Clinical Oncology Dispensary
-
Pyatigorsk, Russie, 357500
- LLC Novaya Clinica
-
Pyatigorsk, Russie, 357502
- Pyatigorsk Interdistrict Oncology Dispensary
-
Saint Petersburg, Russie, 196603
- Private Medical Institution Euromedservice
-
Saint Petersburg, Russie, 191104
- Leningrad Regional Oncology Dispensary
-
Saransk, Russie, 430032
- Republican Oncology Dispensary
-
Tomsk, Russie, 634050
- Tomsk Cancer Research Institute
-
Tyumen, Russie, 625041
- Multifunctional clinical medical center 'Medical city'
-
Ufa, Russie, 450083
- Bashkir State Medical University
-
-
-
-
-
Gothenburg, Suède, 413 45
- Salgrenska University hospital
-
Malmö, Suède, 205 02
- Urologiska Mottagningen
-
Stockholm, Suède, 17164
- Karolinska Universitetssjukhuset Solna
-
Stockholm, Suède, 11883
- Sodersjukhuset
-
-
-
-
-
Kaohsiung City, Taïwan, 83301
- Kaohsiung Chang Gung Memorial Hospital
-
Kaohsiung City, Taïwan, 807
- Kaohsiung Medical University Chung Ho Memorial Hospital
-
Taichung, Taïwan, 40447
- China Medical University Hospital
-
Taichung, Taïwan, 40705
- Taichung Veterans General Hospital
-
Taichung, Taïwan, 435
- Tungs' Taichung MetroHarbor Hospital
-
Taipei, Taïwan, 10002
- National Taiwan University Hospital
-
Taipei, Taïwan, 11217
- Taipei Veterans General Hospital
-
Taoyuan, Taïwan, 333
- Chang-Gung Memorial Hospital, LinKou Branch
-
-
-
-
-
Brno, Tchéquie, 656 91
- Fakultni nemocnice u sv. Anny v Brne
-
Hradec Králové, Tchéquie, 500 05
- FN Hradec Kralove, Urologicka klinika
-
Liberec, Tchéquie, 460 63
- Krajská nemocnice Liberec
-
Olomouc, Tchéquie, 77900
- Uromedical Center s.r.o.
-
Prague, Tchéquie, 128 00
- Urologicka klinika 1 LF UK a VFN
-
-
-
-
-
Bangkok, Thaïlande, 10330
- King Chulalongkorn Memorial Hospital
-
Bangkok, Thaïlande, 10700
- Siriraj Hospital
-
Bangkok, Thaïlande, 10400
- Ramathibodi Hospital
-
-
-
-
-
Adana, Turquie (Türkiye), 01250
- Adana Baskent Yuregir Hospital
-
Ankara, Turquie (Türkiye), 06520
- Memorial Ankara Hastanesi
-
Ankara, Turquie (Türkiye), 06800
- Ankara Bilkent Sehir Hastanesi
-
Ankara, Turquie (Türkiye), 06590
- Ankara University Medical Faculty
-
Ankara, Turquie (Türkiye), 06200
- Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi
-
Ankara, Turquie (Türkiye), 06560
- Gazi Hastanesi
-
Bursa, Turquie (Türkiye), 16310
- Bursa Yuksek lhtisas EAH Medikal Onkoloji Klinigi
-
Edirne, Turquie (Türkiye), 22030
- Trakya University Medical Faculty
-
Istanbul, Turquie (Türkiye), 34147
- Bakirkoy Training and Research Hospital
-
Istanbul, Turquie (Türkiye), 34000
- Istanbul University Istanbul Medical Faculty
-
Istanbul, Turquie (Türkiye), 34098
- Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
-
Istanbul, Turquie (Türkiye), 34722
- T C Saglik Bakanlıgi Goztepe Prof Dr Suleyman Yalcın Sehir Hastanesi
-
Izmir, Turquie (Türkiye), 35530
- Izmir Medical Point Hospital
-
Izmir, Turquie (Türkiye), 35340
- Dokuz Eylul Universitesi Arastirma ve Uygulama Hastanesi
-
Sakarya, Turquie (Türkiye), 54050
- Sakarya Üniversitesi Tıp Fakültesi Hastanesi
-
Samsun, Turquie (Türkiye), 55200
- Medical Park Samsun Hastanesi
-
-
-
-
-
Cherkasy, Ukraine, 18009
- CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
-
Chernivtsi, Ukraine, 58013
- Municipal Non-profit enterprise 'Bukovinian clinical oncology center'
-
Dnipro, Ukraine, 49102
- Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
-
Dnipro, Ukraine, 49100
- Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council
-
Dnipro, Ukraine, 49005
- Ce 'Dnipropetrovsk Regional Clinical Hospital N.A. Mechnikov' of Dnipropetrovsk Rc
-
Ivano-Frankivsk, Ukraine, 76008
- Ivano-Frankivsk Regional Clinical Hospital
-
Kamyanske, Ukraine, 51900
- Communal Institution 'City hospital №7 of Kamianske' of Dnepropetrov'sk Regional Council
-
Khakhiv, Ukraine, 61070
- Municipal non-profit enterprise 'Regional Center of Oncology'
-
Kharkiv, Ukraine, 61037
- Regional Medical Clinical Center for Urology and Nephrology named after V.I. Shapoval
-
Kherson, Ukraine, 73035
- Kherson Regional Oncological Dispensary
-
Kyiv, Ukraine, 04107
- Kyiv Regional Oncological Dispensary
-
Kyiv, Ukraine, 03115
- State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center
-
Kyiv, Ukraine, 03022
- State Nonprofit Enterprise National Cancer Institute
-
Lviv, Ukraine, 79010
- Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital'
-
Vinnitsa, Ukraine, 21029
- Podilskiy Regional Center of Oncology
-
Zhytomyr, Ukraine, 10002
- Municipal non-profit enterprise Zhytomyr Regional Oncology Dispensary of Zhytomyr Regional Council
-
-
-
-
Alabama
-
Homewood, Alabama, États-Unis, 35209
- Urology Centers Of Alabama
-
-
Arizona
-
Phoenix, Arizona, États-Unis, 85054
- Mayo Clinic Arizona
-
Tucson, Arizona, États-Unis, 85741
- Urological Associates of Southern Arizona, P.C.
-
-
California
-
Los Angeles, California, États-Unis, 90073
- Greater Los Angeles VA Healthcare System
-
Orange, California, États-Unis, 92868
- University of California Irvine Medical Center Chao Family Comprehensive Cancer Center
-
San Bernardino, California, États-Unis, 92404
- San Bernardino Urological Associates
-
San Francisco, California, États-Unis, 94158
- University of San Francisco California
-
-
Colorado
-
Colorado Springs, Colorado, États-Unis, 80907
- Rocky Mountain Cancer Centers
-
Denver, Colorado, États-Unis, 80210
- AdventHealth Medical Group Urology of Denver
-
Lakewood, Colorado, États-Unis, 80228
- Colorado Clinical Research
-
-
Connecticut
-
Norwich, Connecticut, États-Unis, 06360
- Eastern Connecticut Hematology & Oncology Assoc.
-
-
Florida
-
Daytona Beach, Florida, États-Unis, 32114
- Advanced Urology Institute
-
Fort Lauderdale, Florida, États-Unis, 33308
- Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center
-
Jacksonville, Florida, États-Unis, 32256
- Cancer Specialists of North Florida
-
Jacksonville, Florida, États-Unis, 32209
- University of Florida Health Jacksonville
-
-
Indiana
-
Greenwood, Indiana, États-Unis, 46143
- Urology of Indiana
-
Jeffersonville, Indiana, États-Unis, 47130
- First Urology
-
-
Louisiana
-
New Orleans, Louisiana, États-Unis, 70121
- Ochsner Clinic Foundation
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21201
- Baltimore VA Medical Center
-
Columbia, Maryland, États-Unis, 21044
- Maryland Oncology Hematology, PA
-
Towson, Maryland, États-Unis, 21204
- Chesapeake Urology Associates
-
-
Michigan
-
Troy, Michigan, États-Unis, 48084
- Michigan Institute of Urology
-
-
Missouri
-
Saint Joseph, Missouri, États-Unis, 64507
- Mosaic Life Care
-
St Louis, Missouri, États-Unis, 63109
- St. Louis VA Medical Center
-
-
Nebraska
-
Omaha, Nebraska, États-Unis, 68130
- GU Research Network
-
-
New York
-
Albany, New York, États-Unis, 12206
- New York Oncology Hematology
-
New York, New York, États-Unis, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, États-Unis, 10029
- Mount Sinai
-
New York, New York, États-Unis, 10010
- Manhattan VAMC
-
Syracuse, New York, États-Unis, 13210
- Associated Medical Professionals
-
The Bronx, New York, États-Unis, 10461
- Montefiore Medical Center
-
-
North Carolina
-
Durham, North Carolina, États-Unis, 27705
- Durham VAMC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, États-Unis, 73104
- Stephenson Cancer Center
-
-
Oregon
-
Portland, Oregon, États-Unis, 97239
- VA Portland Health Care System
-
Salem, Oregon, États-Unis, 97301
- Oregon Oncology Specialists
-
-
Pennsylvania
-
Lancaster, Pennsylvania, États-Unis, 17604
- Keystone Urology Specialists
-
Philadelphia, Pennsylvania, États-Unis, 19104
- University of Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Philadelphia VA Medical Center
-
Pittsburgh, Pennsylvania, États-Unis, 15232
- University of Pittsburgh Medical Center (UPMC)
-
-
South Carolina
-
Charleston, South Carolina, États-Unis, 29401
- Ralph H. Johnson Veterans Affairs Medical Center
-
Seneca, South Carolina, États-Unis, 29672
- Prisma Health
-
-
Tennessee
-
Nashville, Tennessee, États-Unis, 37209
- Urology Associates
-
-
Texas
-
Austin, Texas, États-Unis, 78731
- Texas Oncology-Austin
-
Denton, Texas, États-Unis, 76201
- Texas Oncology - Northeast
-
Houston, Texas, États-Unis, 77027
- Houston Metro Urology
-
New Braunfels, Texas, États-Unis, 78130
- Texas Oncology P A
-
Tyler, Texas, États-Unis, 75702
- Texas Oncology - Northeast 1
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84112
- University of Utah Huntsman Cancer Institute
-
-
Virginia
-
Norfolk, Virginia, États-Unis, 23502
- Virginia Oncology Associates
-
Richmond, Virginia, États-Unis, 23298
- Virginia Commonwealth University - Massey Cancer Center
-
-
Washington
-
Seattle, Washington, États-Unis, 98109
- Fred Hutchinson Cancer Research Center
-
Seattle, Washington, États-Unis, 98108
- VA Puget Sound Healthcare System
-
Tacoma, Washington, États-Unis, 98405
- MultiCare Health System
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion criteria:
- Pathological diagnosis of prostate adenocarcinoma
- Must have appropriate deleterious homologous recombination repair (HRR) gene alteration
- Metastatic disease as documented by conventional imaging with computed tomography (CT) or magnetic resonance imaging (MRI) (for soft tissue lesions) or 99mTc bone scan (for bone lesions). Participants with a single bone lesion on Technetium-99m (99mTc) bone scan with no other non-nodal metastatic disease must have confirmation of bone metastasis by CT or MRI. Participants with lymph node-only disease are not eligible
- Androgen deprivation therapy (either medical or surgical castration) must have been started >=14 days prior to randomization and participants be willing to continue androgen deprivation therapy (ADT) through the treatment phase
- Other allowed prior therapy for metastatic castration-sensitive prostate cancer (mCSPC): (a) maximum of 1 course of radiation and 1 surgical intervention for symptomatic control of prostate cancer (example, uncontrolled pain, impending spinal cord compression or obstructive symptoms). Participants with radiation or surgical interventions to all known sites of metastatic disease will be excluded from trial participation. Radiation must be completed prior to randomization (b) Up to a maximum of 6 months of ADT prior to randomization; (c) Up to a maximum of 45 days of abiraterone acetate + prednisone (AA-P) prior to randomization (d) Up to a maximum of 2 weeks of ketoconazole for prostate cancer prior to randomization
Exclusion criteria:
- Prior treatment with a poly (adenosine diphosphate-ribose) polymerase inhibitor (PARP inhibitor)
- History of adrenal dysfunction
- Long-term use of systemically administered corticosteroids (greater than [>] 5 milligrams [mg] of prednisone or the equivalent) during the study is not allowed. Short-term use (<=4 weeks, including taper) and locally administered steroids (for example, inhaled, topical, ophthalmic, and intra-articular) are allowed, if clinically indicated
- History or current diagnosis of myelodysplastic syndrome (MDS)/ acute myeloid leukemia (AML)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Niraparib with Abiraterone Acetate plus Prednisone (AAP)
Participants will receive the following in each 28-day treatment cycle: niraparib 200 milligrams (mg) + abiraterone acetate (AA) 1000 mg fixed dose combination (FDC) along with placebo for AA and prednisone 5 mg once daily. |
Participants will receive a FDC of Niraparib 200 mg + AA 1000 mg once daily. Participants will receive prednisone 5 mg once daily. Participants will receive matching placebo for AA once daily. |
|
Comparateur actif: Placebo for Niraparib + AA FDC plus AA and prednisone (AAP)
Participants will receive the following in each 28-day treatment cycle: matching placebo for Niraparib+AA FDC along with AA 1000 mg and prednisone 5 mg once daily. |
Participants will receive prednisone 5 mg once daily. Participants will receive AA 1000 mg once daily. Participants will receive matching placebo for Niraparib +AA FDC once daily. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Délai: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI) per response evaluation criteria in solid tumors (RECIST) 1.1; (2) progression of bone lesions observed by bone scan per prostate cancer working group 3 (PCWG3) criteria: bone progression was confirmed by subsequent scan greater than or equal to (>=) 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
HRR Effector Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Délai: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
All HRR: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Délai: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Survie globale (OS)
Délai: De la date de randomisation (Jour -3 à Jour 1) jusqu'à 83 mois
|
De la date de randomisation (Jour -3 à Jour 1) jusqu'à 83 mois
|
|
|
Délai jusqu'à la thérapie subséquente
Délai: De la date de randomisation (Jour -3 à Jour 1) jusqu'à 83 mois
|
De la date de randomisation (Jour -3 à Jour 1) jusqu'à 83 mois
|
|
|
Nombre de participants présentant des événements indésirables graves survenus sous traitement
Délai: Du jour 1 du cycle 1 jusqu'à 83 mois
|
Du jour 1 du cycle 1 jusqu'à 83 mois
|
|
|
Nombre de participants présentant des événements indésirables émergents du traitement par gravité
Délai: Du Cycle 1 Jour 1 jusqu'à 83 mois
|
Du Cycle 1 Jour 1 jusqu'à 83 mois
|
|
|
BRCA Subgroup: Time to Symptomatic Progression
Délai: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
HRR Effector Subgroup: Time to Symptomatic Progression
Délai: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
All HRR: Time to Symptomatic Progression
Délai: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies génitales
- Tumeurs génitales, homme
- Tumeurs urogénitales
- Tumeurs par site
- Tumeurs
- Maladies génitales, sexe masculin
- Maladies de la prostate
- Maladies urogénitales masculines
- Tumeurs prostatiques
- Composés polycycliques
- Prégnades
- Grossesse
- Stéroïdes
- Composés à anneau fusionné
- Grossissements
- Androsténes
- Androstanes
- Acétate d'abiratérone
- Prednisone
Autres numéros d'identification d'étude
- CR108852
- 2020-002209-25 (Numéro EudraCT)
- 67652000PCR3002 (Autre identifiant: Janssen Research & Development, LLC)
- 2023-506365-64-00 (Identificateur de registre: EUCT number)
- 2023 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
The data sharing policy of Johnson & Johnson Innovative Medicine is available at innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .